Back to News
Market Impact: 0.25

Morgan Stanley assumes Spotify stock coverage with overweight rating By Investing.com

SPOTMSEVRBAC
Analyst InsightsAnalyst EstimatesCompany FundamentalsCorporate Guidance & OutlookMedia & EntertainmentTechnology & InnovationM&A & RestructuringManagement & Governance
Morgan Stanley assumes Spotify stock coverage with overweight rating By Investing.com

Morgan Stanley initiated Spotify with an overweight rating and a $630 price target, implying upside from the current $476 share price despite trimming EBITDA and free cash flow estimates by about 2%. The firm still expects roughly 35% EBIT CAGR and 20% free cash flow CAGR through 2028, with paying users topping 300 million and monthly active users exceeding 800 million this year. Recent updates also included multiple analyst target cuts, a $800 bullish target from Citizens, and a 3% podcast-unit headcount reduction as Spotify continues restructuring.

Analysis

SPOT remains the cleanest secular winner in the group, but the more interesting angle is that the upside is increasingly coming from operating leverage rather than pure top-line surprise. If management can hold pricing and migrate mix toward higher-margin verticals, the market will likely re-rate the stock on quality of cash flow, not just user growth; that argues for multiple support even if revenue growth moderates. The second-order effect is that rising profitability could intensify competitive pressure on smaller audio/podcast players that lack comparable scale economics, especially if Spotify keeps pruning lower-return content bets. The setup is still asymmetric, but the window is time-sensitive: the next 1-2 quarters matter more than the 2-3 year model. The main risk is that expense inflation or heavier creator/content investment offsets margin expansion, which would force the market to question the credibility of the 2027-2028 free-cash-flow ramp. A softer path to the 300M+ payer milestone would also matter less for fundamentals than for sentiment, because the stock is now in the zone where any miss on monetization efficiency can trigger multiple compression. The consensus appears to be underestimating how much of the stock’s beta is now tied to execution consistency rather than growth optionality. In other words, this is no longer a “can they grow?” debate; it is a “can they convert growth into durable margin” debate. That makes the stock more vulnerable to a short-term drawdown on any evidence of cost creep, but also more likely to outperform if quarterly gross-margin progression continues to step up faster than expected.